Use of the polymerase chain reaction technique to determine c-myc expression in follicular center cell lymphoma

Diagnostic Molecular Pathology

Volumn 5, Issue 1, 1996, Pages 20-25

  Wang, Jiun ^a   Medeiros, L Jeffrey ^a,c   Longo, Dan L ^b   Mansoor, Adnan ^a   Raffeid, Mark ^a   Duffey, Patricia L ^b   Jaffe, Elaine S ^a   Stetler Stevenson, Maryalice ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

c myc Expression; cDNA; Follicular center cell lymphoma; Polymerase chain reaction; Reverse transcription; RNA

Indexed keywords

BETA 2 MICROGLOBULIN;

ADOLESCENT; ARTICLE; CASE REPORT; CELL CULTURE; DNA SYNTHESIS; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOMA; MALE; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ADULT; BASE SEQUENCE; BLOTTING, NORTHERN; BURKITT LYMPHOMA; FEMALE; GENES, MYC; HUMANS; LYMPHOMA, SMALL CLEAVED-CELL, FOLLICULAR; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0030049762     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199603000-00004     Document Type: Article

References (15)

1. Battey J, Moulding C, Taub R, et al. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 1983;34:779-87.
2. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119-28.
3. Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ. Expression of bcl-2 and bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 1987;80:1512-15.
4. 2-microglobulin gene, primary structure and definition of the transcriptional unit. J Immunol 1987;139:3132-8.
5. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
6. Limpens J, de Jong D, Van Krieken JHJM, Price CGA, Young BD, van Ommen GIB, Kluin PM: Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991;6:2271-6.
7. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991-,349:254-6.
8. Raffeld M, Wright J, Lipford E, et al. Clonal evolution of t(14;18) follicular lymphomas demonstrated by immunoglobulin genes and the 18q21 major breakpoint region. Cancer Res 1987;47:2537-42.
9. Rowley JD. Identification of the chromosomal region involved in human hematologic malignancies. Science 1982;216:749-51.
10. Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991;77:1516-26.
11. Stetler-Stevenson MA, Raffeld M, Cohen P, Cossman J. Detection of occult follicular lymphoma by specific DNA amplification. Blood 1988;72:1822-5.
12. VanderMolen LA, Duffey PL, Cossman J, Jaffe ES, Longo DL. Surface light chain phenotype in indolent lymphomas: Lack of clinical significance. Am J Hematol 1990;34:15-20.
13. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1990;355:440-2.
14. Yano T, Jaffe ES, Longo DL, Raffeld M. Myc rearrangements in histologically progressed follicular lymphomas. Blood 1992;80:758-67.
15. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M. Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. N Engl J Med 1987;316:79-84.